Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Equity Ratio: 2014-2023

Historic Equity Ratio for Cellectis (CLLS) over the last 9 years, with Sep 2023 value amounting to 0.36.

  • Cellectis' Equity Ratio rose 11224.17% to 0.36 in Q3 2023 from the same period last year, while for Sep 2023 it was 0.36, marking a year-over-year increase of 11224.17%. This contributed to the annual value of 0.04 for FY2022, which is 1604.10% up from last year.
  • Per Cellectis' latest filing, its Equity Ratio stood at 0.36 for Q3 2023, which was up 679.69% from 0.05 recorded in Q2 2023.
  • Cellectis' 5-year Equity Ratio high stood at 0.76 for Q1 2019, and its period low was 0.00 during Q3 2022.
  • Its 3-year average for Equity Ratio is 0.35, with a median of 0.48 in 2022.
  • In the last 5 years, Cellectis' Equity Ratio slumped by 99.44% in 2022 and then spiked by 11,224.17% in 2023.
  • Cellectis' Equity Ratio (Quarterly) stood at 0.02 in 2019, then surged by 3,079.45% to 0.66 in 2020, then dropped by 5.92% to 0.62 in 2021, then dropped by 22.10% to 0.48 in 2022, then soared by 11,224.17% to 0.36 in 2023.
  • Its last three reported values are 0.36 in Q3 2023, 0.05 for Q2 2023, and 0.00 during Q1 2023.